Behrouz Kassai

Professor

Université Claude Bernard Lyon 1

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Behrouz Kassai is a faculty member at Claude Bernard University Lyon 1 in France. His research areas encompass pediatric pharmaceuticals, endocrine disruptors, and preoperative imaging techniques, as well as the clinical characteristics of various pediatric conditions. Recent articles authored by Professor Kassai include studies on the impact of unlicensed drug prescriptions, management of pediatric toxic shock syndrome, and ADHD treatments. His work contributes significantly to advancing pediatric care and understanding the effects of medications in children.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Sherif Eltonsy

Assistant Professor

University of Manitoba

CANADA

View details

Encarnita Mariotti-Ferrandiz

Associate professor

Sorbonne Université

FRANCE

View details

René Ecochard

Head

University of Lyon

FRANCE

View details

Sylvain Rheims

FRANCE

View details

Rémy Boussageon

Université Claude Bernard Lyon 1

FRANCE

View details

Laurent Remontet

Université Claude Bernard Lyon 1

FRANCE

View details

Laure Guittard

Université Claude Bernard Lyon 1 - Domaine de Rockefeller

FRANCE

View details

Kieran O'Donnell

Assistant Professor

Yale University

UNITED STATES

View details

Paul Bastard

Imagine Institute for Genetic Diseases

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Behrouz Kassai

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Phosphatidylserine enriched with polyunsaturated n‐3 fatty acid supplementation for attention‐deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo‐controlled trial

Tiny pills, big impacts: A systematic review on the endocrine disrupting effects of paediatric pharmaceuticals.

Knowledge and beliefs of endocrine disruptors in pediatrics: all hands on deck!

Preoperative 11C-Methionine PET-MRI in Pediatric Infratentorial Tumors

Clinical Characteristics, Developmental Trajectory, and Caregiver Burden of Patients With Creatine Transporter Deficiency ( <i>SLC6A8</i> )

High-dose intravenous immunoglobulin versus albumin 4% in paediatric toxic shock syndrome: a randomised controlled feasibility study.

Unlicensed/Off-Label Drug Prescriptions at Hospital Discharge in Children: An Observational Study Using Routinely Collected Health Data

[Does aspirin have a place in primary cardiovascular prevention by the polypill ? Simulation study on a realistic virtual population].

Anesthesia practices for management of labor pain and cesarean delivery in France (EPIDOL): A cross-sectional survey.

The COVID-19 Pandemic Impacted Maternal Mental Health Differently Depending on Pregnancy Status and Trimester of Gestation

Trigger tools to identify adverse drug events in hospitalised children: A systematic review

Project rebuild the evidence base (REB): A method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients.

Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol

Polyclonal expansion of TCR Vbeta 21.3+ CD4+ and CD8+ T cells is a hallmark of Multisystem Inflammatory Syndrome in Children

Agreement between a regional pharmacovigilance centre and an adjudication committee regarding drug adverse reactions on a cohort of hospitalised children.

Prevalence and duration of prescribed opioid use during pregnancy: a cohort study from the Quebec Pregnancy Cohort.

Replacing liquid with solid dosage forms in pediatric practice: Feasibility and economic impact from a hospital-based study

Protocol of controlled odorant stimulation for reducing apnoeic episodes in premature newborns: a randomised open-label Latin-square study with independent evaluation of the main endpoint (PREMODEUR).

Available medications used as potential therapeutics for COVID-19: What are the known safety profiles in pregnancy.

Determination of the optimal dose of ephedrine in the treatment of arterial hypotension due to general anesthesia in neonates and infants below 6 months old: the ephedrine study protocol for a randomized, open-label, controlled, dose escalation trial.

Collaborators (9)

Sherif Eltonsy

Encarnita Mariotti-Ferrandiz

René Ecochard

Sylvain Rheims

Rémy Boussageon

Laurent Remontet

Laure Guittard

Kieran O'Donnell

Paul Bastard

Make your next move.